ArticleACS infectious diseases2025

Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against

Maite Sainz-Mejías et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.